Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maraveyas

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|June 4, 2009
Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?A Maraveyas, M Johnson
Anticancer Research|February 26, 2004
Subcutaneous levomepromazine rescue (SLR) for high grade delayed chemotherapy-induced emesis (DCIE)H L McCabe, A Maraveyas
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Targeted immunotherapy. An update with special emphasis on ovarian cancerA Maraveyas, A A Epenetos
Cancer Immunology, Immunotherapy : CII|January 1, 1991
An overview of radioimmunotherapyA Maraveyas, A A Epenetos
Journal of Thrombosis and Haemostasis : JTH|October 14, 2017
Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancerK Date, C Ettelaie, A Maraveyas
Thrombosis Research|May 11, 2016
PO-27 - Thrombin generation in pancreatic cancer and multiple myeloma with use of calibrated automated thrombographyM A Adesanya, A Maraveyas, L A Madden
British Journal of Cancer|April 1, 1995
Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft modelG Rowlinson-Busza, A Maraveyas, A A Epenetos
Thrombosis Research|May 11, 2016
PO-39 - Primary thromboprophylaxis for ambulatory patients with advanced metastatic pancreatic cancer. A practical implementation of lessons from published experienceG Bozas, I A Muazzam, W Ilyas, et al.
Thrombosis Research|May 11, 2016
PO-30 - Changes in soluble CD106 and CD54 serum levels during chemotherapy treatment for multiple myelomaJ Hall, M A Adesanya, L A Madden, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2007
13-cis-Retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastatic pancreatic cancer--report of a pilot phase II studyA Michael, M Hill, A Maraveyas, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|June 4, 2009
Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?A Maraveyas, M Johnson
Anticancer Research|February 26, 2004
Subcutaneous levomepromazine rescue (SLR) for high grade delayed chemotherapy-induced emesis (DCIE)H L McCabe, A Maraveyas
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Targeted immunotherapy. An update with special emphasis on ovarian cancerA Maraveyas, A A Epenetos
Cancer Immunology, Immunotherapy : CII|January 1, 1991
An overview of radioimmunotherapyA Maraveyas, A A Epenetos
Journal of Thrombosis and Haemostasis : JTH|October 14, 2017
Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancerK Date, C Ettelaie, A Maraveyas
Thrombosis Research|May 11, 2016
PO-27 - Thrombin generation in pancreatic cancer and multiple myeloma with use of calibrated automated thrombographyM A Adesanya, A Maraveyas, L A Madden
British Journal of Cancer|April 1, 1995
Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft modelG Rowlinson-Busza, A Maraveyas, A A Epenetos
Thrombosis Research|May 11, 2016
PO-39 - Primary thromboprophylaxis for ambulatory patients with advanced metastatic pancreatic cancer. A practical implementation of lessons from published experienceG Bozas, I A Muazzam, W Ilyas, et al.
Thrombosis Research|May 11, 2016
PO-30 - Changes in soluble CD106 and CD54 serum levels during chemotherapy treatment for multiple myelomaJ Hall, M A Adesanya, L A Madden, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2007
13-cis-Retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastatic pancreatic cancer--report of a pilot phase II studyA Michael, M Hill, A Maraveyas, et al.
Pageof 4